Quinquenoside III

[3,4-dihydroxy-6-[[12-hydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl acetate

PXHNTRFQGHWVGX-UHFFFAOYSA-N CHEBI:191596 0 Reactome links 2 studies
2 Observed studies
2 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
PXHNTRFQGHWVGX-UHFFFAOYSA-N
IUPAC name
[3,4-dihydroxy-6-[[12-hydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl acetate
Preferred name
Quinquenoside III
INN name
Synonym
ChEBI
CHEBI:191596

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles